Who
Peter J. Werth
Director
Company insider
Files Form 4 as: Director and 10% owner, Cingulate.
In numbers
- Trades disclosed
- 25
- Buys
- 6
- Sells
- 0
- Bought
- $1.4M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 Dec 2021
- Last trade
- 16 Jul 2026
- Last filed
- 20 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING CingulateBiotechnology | SEC FORM 4 Bought | $98K19,455 at $5.04 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $1,55615,564 at $0.10 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $1,55615,564 at $0.10 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING CingulateBiotechnology | SEC FORM 4 Bought | $98K19,455 at $5.04 | filing |
| 20 Jun 2025filed 23 Jun 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 12 Jun 2024filed 13 Jun 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,926 | filing |
| 11 Apr 2024filed 12 Apr 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code M | —341,912 at $0.00 | filing |
| 11 Apr 2024filed 12 Apr 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code M | —694,096 at $0.00 | filing |
| 11 Apr 2024filed 12 Apr 2024 | CING CingulateBiotechnology | SEC FORM 4 Code M | —341,912 at $0.00 | filing |
| 11 Apr 2024filed 12 Apr 2024 | CING CingulateBiotechnology | SEC FORM 4 Code M | —694,096 at $0.00 | filing |
| 25 Mar 2024filed 27 Mar 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code J | —7,053 | filing |
| 4 Mar 2024filed 6 Mar 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,824 | filing |
| 25 Jan 2024filed 29 Jan 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code J | —687,043 | filing |
| 11 Aug 2023filed 14 Aug 2023 | CING CingulateBiotechnology | SEC FORM 4 Bought | $1.0M1,823,155 at $0.55 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 13 Dec 2022filed 15 Dec 2022 | CING CingulateBiotechnology | SEC FORM 4 Bought | $28K28,934 at $0.98 | filing |
| 6 Sep 2022filed 8 Sep 2022 | CING CingulateBiotechnology | SEC FORM 4 Bought | $113K74,500 at $1.52 | filing |
News
No headline names them, or the companies they trade most, lately.